Report says Theranos CEO’s role will likely remain the same
After the Centers for Medicare & Medicaid Services sanctioned Theranos and forbid founder and CEO Elizabeth Holmes from owning or operating a laboratory for two years, Forbes wonders how the penalties will affect the company. Despite the issues, sources told Forbes that Holmes’s role would not change.
The report also mentions that the Securities and Exchange Commission and the Department of Justice are examining Theranos’s operations and that the company has not made its data available to doctors and scientists to evalutate.
Read the full story below.
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.